Haemodynamic unloading reverses occlusive vascular lesions in severe pulmonary hypertension

Cardiovasc Res. 2016 Jul 1;111(1):16-25. doi: 10.1093/cvr/cvw070. Epub 2016 Apr 1.

Abstract

Aims: An important pathogenic mechanism in the development of idiopathic pulmonary arterial hypertension is hypothesized to be a cancer-like cellular proliferation independent of haemodynamics. However, because the vascular lesions are inseparably coupled with haemodynamic stress, the fate of the lesions is unknown when haemodynamic stress is eliminated.

Methods and results: We applied left pulmonary artery banding to a rat model with advanced pulmonary hypertension to investigate the effects of decreased haemodynamic stress on occlusive vascular lesions. Rats were given an injection of the VEGF blocker Sugen5416 and exposed to 3 weeks of hypoxia plus an additional 7 weeks of normoxia (total 10 weeks) (SU/Hx/Nx rats). The banding surgery to reduce haemodynamic stress to the left lung was done at 1 week prior to (preventive) or 5 weeks after (reversal) the SU5416 injection. All SU/Hx/Nx-exposed rats developed severe pulmonary hypertension and right ventricular hypertrophy. Histological analyses showed that the non-banded right lungs developed occlusive lesions including plexiform lesions with marked perivascular cell accumulation. In contrast, banding the left pulmonary artery not only prevented the development of but also reversed the established occlusive lesions as well as perivascular inflammation in the left lungs.

Conclusion: Our results indicate that haemodynamic stress is prerequisite to the development and progression of occlusive neointimal lesions in this rat model of severe pulmonary hypertension. We conclude that perivascular inflammation and occlusive neointimal arteriopathy are driven by haemodynamic stress.

Keywords: Haemodynamic stress; Occlusive lesion formation; Pulmonary arterial hypertension.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Angiogenesis Inhibitors
  • Animals
  • Arterial Occlusive Diseases / etiology
  • Arterial Occlusive Diseases / metabolism
  • Arterial Occlusive Diseases / pathology
  • Arterial Occlusive Diseases / physiopathology*
  • Cell Proliferation
  • Cytokines / genetics
  • Cytokines / metabolism
  • Disease Models, Animal
  • Familial Primary Pulmonary Hypertension / etiology
  • Familial Primary Pulmonary Hypertension / metabolism
  • Familial Primary Pulmonary Hypertension / pathology
  • Familial Primary Pulmonary Hypertension / physiopathology*
  • Hemodynamics*
  • Hypoxia / complications
  • Inflammation / etiology
  • Inflammation / metabolism
  • Inflammation / pathology
  • Inflammation / physiopathology*
  • Inflammation Mediators / metabolism
  • Ligation
  • Male
  • Neointima*
  • Pulmonary Artery / metabolism
  • Pulmonary Artery / pathology
  • Pulmonary Artery / physiopathology*
  • Pulmonary Artery / surgery
  • Pulmonary Circulation
  • Rats, Sprague-Dawley
  • Severity of Illness Index
  • Transcription Factor RelA / metabolism
  • Vascular Remodeling*

Substances

  • Angiogenesis Inhibitors
  • Cytokines
  • Inflammation Mediators
  • Rela protein, rat
  • Transcription Factor RelA